logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The aviation engine sector continues to rise, and AVIC Aircraft Integration is at the limit up.

date
12/06/2026
The aviation engine sector continues to rise, with AviChina Industry & Technology hitting the limit up. Prior to this, stocks such as Aviation Power Technology, Antai Technology, and Sunrise Aviation also hit the limit up.
Latest
4 m ago
Leveraged ETF trading frenzy shifts to reverse: Nearly 70% of SK Hynix's trading volume comes from derivative hedging.
5 m ago
Hong Kong stocks are volatile | Aluminum stocks collectively rise as London aluminum inventory hits a 20-year low. Institutions are optimistic about investment opportunities in the domestic aluminum industry chain.
7 m ago
Hong Kong stock anomaly | China Xinlianxin Chemical Fertilizer (01866.HK) rose more than 6% in early trading and will distribute year-end dividends at the end of next month. The dividend payout ratio has significantly increased to 44%.
8 m ago
The Indian NIFTY index rose 1.1% in pre-market trading to 23412.55 points.
9 m ago
Amgen (AMGN.US) hires Duke Clinical Research Institute for independent re-evaluation to ensure the flagship drug Tavneos is not delisted.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.